Fructose-1,6-bisphosphatase is a novel regulator of Wnt/β-Catenin pathway in breast cancer
- 1 December 2016
- journal article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 84, 1144-1149
- https://doi.org/10.1016/j.biopha.2016.10.050
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular CarcinomaCancer Research, 2016
- Intratumor Heterogeneity in Breast CancerPublished by Springer Science and Business Media LLC ,2016
- Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cellsMolecular and Cellular Biochemistry, 2015
- Down Expression of FBP1 Is a Negative Prognostic Factor for Non–Small-Cell Lung CancerCancer Investigation, 2015
- Fructose-1,6-bisphosphatase opposes renal carcinoma progressionNature, 2014
- Breast cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon CancerPLOS ONE, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Determining and understanding the control of glycolysis in fast‐growth tumor cellsThe FEBS Journal, 2006
- The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphateStructure, 1998